• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cogent Biosciences, Inc. - Common Stock (NQ:COGT)

    31.32 -0.64 (-2.00%)
    Delayed Quote Updated: 11:07 AM EDT, Oct 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cogent Biosciences, Inc. - Common Stock

    < Previous 1 2 3 4 5 Next >
    News headline image
    Analyst Expectations for Cogent Biosciences's Future ↗
     
    Via Benzinga
    News headline image
    Unpacking Blueprint Medicines' Ayvakit's Bright Future: Insights From Latest Physician Survey On Sales Predictions ↗
    Needham slightly increased the price target for Blueprint Medicines Corp (NASDAQ: BPMC) from $65 to $66  
    Via Benzinga
    News headline image
    $10M Bet On GameStop? Check Out These 3 Stocks Insiders Are Buying ↗
    Although US stocks closed higher on Tuesday, there were a few notable insider trades. 
    Via Benzinga
    News headline image
    9 Analysts Have This to Say About Cogent Biosciences ↗
     
    Via Benzinga
    News headline image
    Calavo Growers, Mondee Holdings And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
    U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
    Via Benzinga
    News headline image
    Recap: Cogent Biosciences Q1 Earnings ↗
    Cogent Biosciences (NASDAQ:COGT) reported its Q1 earnings results on Tuesday, May 9, 2023 at 08:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    News headline image
    Analyst Ratings for Cogent Biosciences ↗
     
    Via Benzinga
    News headline image
    Expert Ratings for Cogent Biosciences ↗
     
    Via Benzinga
    News headline image
    4 Analysts Have This to Say About Cogent Biosciences ↗
     
    Via Benzinga
    What 4 Analyst Ratings Have To Say About Cogent Biosciences ↗
     
    Via Benzinga
    News headline image
    Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
    Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for... 
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2023 ↗
     
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗
     
    Via Benzinga
    News headline image
    Pinterest To Rally Around 23%? Here Are 10 Other Price Target Changes For Tuesday ↗
     
    Via Benzinga
    News headline image
    Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗
    Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share. 
    Via Benzinga
    News headline image
    Cogent Biosciences Touts Positive Data From Bezuclastinib Study In Mastocytosis Patients ↗
     
    Via Benzinga
    News headline image
    This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗
    Gainers 
    Via Benzinga
    News headline image
    Denbury, Global-e Online And Agilent Among Top Gainers On Wednesday ↗
    U.S. stocks closed lower on Wednesday, with the Dow Jones dropping around 170 points. Here is the list of some big stocks moving higher in the previous session. 
    Via Benzinga
    News headline image
    Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session ↗
    Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus... 
    Via Benzinga
    News headline image
    Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names ↗
    Biotech stocks continued going gangbusters Wednesday. Here's why, experts say. 
    Via Investor's Business Daily
    News headline image
    Do You Have Biotech FOMO? Why Cogent, Arvinas And Others Are Flying ↗
    Biotech stocks continued going gangbusters Wednesday. Here's why, experts say. 
    Via Investor's Business Daily
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022 ↗
    Upgrades 
    Via Benzinga
    News headline image
    89 Biggest Movers From Friday ↗
    Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. 
    Via Benzinga
    News headline image
    Cboe's Weekly Market Recap: June 6th To 10th ↗
    Exciting developments occurred on the Cboe Global Markets Inc. (BATS: CBOE) this week. 
    Via Benzinga
    News headline image
    91 Biggest Movers From Friday ↗
    Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto. 
    Via Benzinga
    News headline image
    Mid-Afternoon Market Update: Dow Drops Over 600 Points; Fulcrum Therapeutics Shares Tumble ↗
    U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 600 points on Friday. 
    Via Benzinga
    News headline image
    Cogent Biosciences (COGT) Stock Soars 90% on Positive Clinical Data ↗
    Today, investors in Cogent Biosciences and COGT stock have some promising clinical trial results to look at, as this stock soars. 
    Via InvestorPlace
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Why Shares Of Cogent Biosciences Are Trading Higher ↗
    Cogent Biosciences, Inc. (NASDAQ: COGT) shares are trading higher after the company reported initial data from its ongoing Phase 2 APEX clinical trial. 
    Via Benzinga
    News headline image
    Mid-Day Market Update: Nasdaq Dips 400 Points; Cogent Biosciences Shares Jump ↗
    U.S. stocks traded lower midway through trading, with the Nasdaq Composite tumbling around 400 points on Friday. 
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.